The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc. (“Meridian”) (NASDAQ: VIVO) securities between March 25, 2016 and July 13, 2017.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Defendant’s lead tests provide inaccurate results; and (ii) as a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Meridian you have until January 16, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
To receive more information, please fill out the form.